Skip to main content
Fig. 2 | European Journal of Medical Research

Fig. 2

From: The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy

Fig. 2

The IgG amount, titer, subclass, and affinity of anti-PLA2R antibodies. HC group: healthy controls; Ab- group: the PLA2R-MN patients with negative antibody (Ab); Ab + group: the PLA2R-MN patients with positive anti-PLA2R antibodies. A: The amount of anti-PLA2R IgG in the three groups. B: The percentage of anti-PLA2R IgG in total IgG. C: The IgG titer of anti-PLA2R antibodies. D: The percentage of each IgG subclass in anti-PLA2R antibodies; E. The IgG affinity of anti-PLA2R antibodies in the three groups. F: The binding of purified anti-PLA2R antibodies to recombinant human PLA2R in SPR. G: The comparisons of antibody affinity among the three groups. * P < 0.05

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us